Literature DB >> 12676170

A local pancreatic renin-angiotensin system: endocrine and exocrine roles.

Po Sing Leung1, Mark C Chappell.   

Abstract

The renin-angiotensin system (RAS) is classically characterized as a circulating hormonal system primarily through the production of the physiologically active product angiotensin II (Ang II) that plays a crucial role in the regulation of blood pressure, fluid and electrolyte homeostasis. In addition to this circulating RAS, numerous tissues and organs have been recently demonstrated to exhibit their own RAS products and activities. Such an intrinsic RAS can modulate the specific local functions of their respective tissues and organs, frequently in a paracrine and autocrine manner. Recent findings from our laboratories and others have made a significant contribution on the expression, localization, regulation, and potential role of a local RAS in the pancreas. Although, it is quite intriguing that components of the local pancreatic RAS are responsive to various physiological and pathophysiological conditions, the crucial role of this system in regulating the exocrine and endocrine functions and ultimately the clinical relevance to pancreatic disease is still largely equivocal. Of particular interest in this context are the actions of pancreatic RAS on the growth, anti-proliferation and free radical generation in the pancreas. The aims of the current article focus on the emerging data on the local pancreatic RAS; its involvement in exocrine acinar and endocrine islet aspects, and the clinical significance in the pancreas are particularly addressed. The target for the local pancreatic RAS may provide a new insight into future management of various clinical conditions including islet transplants, diabetes mellitus, pancreatic cancer, pancreatitis and cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676170     DOI: 10.1016/s1357-2725(02)00179-6

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  27 in total

1.  Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets.

Authors:  T Lau; P-O Carlsson; P S Leung
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

2.  Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer.

Authors:  Marcelo Cerullo; Faiz Gani; Sophia Y Chen; Joseph K Canner; Timothy M Pawlik
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

Review 3.  Vitamin D and cardiovascular risk.

Authors:  Shweta R Motiwala; Thomas J Wang
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

4.  Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.

Authors:  Melvin R Hayden; James R Sowers
Journal:  J Am Soc Hypertens       Date:  2008-06-02

5.  Renal dysfunction, metabolic syndrome and cardiovascular disease mortality.

Authors:  David Martins; Chizobam Ani; Deyu Pan; Omolola Ogunyemi; Keith Norris
Journal:  J Nutr Metab       Date:  2010-03-24

6.  Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma.

Authors:  S T Glenn; C A Jones; S Sexton; C M LeVea; S M Caraker; G Hajduczok; K W Gross
Journal:  Oncogene       Date:  2013-12-02       Impact factor: 9.867

7.  Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.

Authors:  Rathai Anandanadesan; Qiaoke Gong; Galina Chipitsyna; Agnes Witkiewicz; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2007-11-17       Impact factor: 3.452

8.  Angiotensin II regulates the expression of monocyte chemoattractant protein-1 in pancreatic cancer cells.

Authors:  Navdeep Chehl; Qiaoke Gong; Galina Chipitsyna; Tamer Aziz; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2009-10-09       Impact factor: 3.452

9.  Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat.

Authors:  Javad Habibi; Adam Whaley-Connell; Melvin R Hayden; Vincent G DeMarco; Rebecca Schneider; Susan D Sowers; Poorna Karuparthi; Carlos M Ferrario; James R Sowers
Journal:  Endocrinology       Date:  2008-07-24       Impact factor: 4.736

10.  Activation of angiotensin type 2 receptors partially ameliorates streptozotocin-induced diabetes in male rats by islet protection.

Authors:  Chunhong Shao; Li Yu; Lie Gao
Journal:  Endocrinology       Date:  2013-12-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.